Korean Market
EXCH
Tego Science
★

Decision to Acquire 95.77% Stake in P&N Pharm for about 3.74 Billion Won

 
PERI
Tego Science
★

Tego Science Reports Q1 2026 Operating Loss of KRW 1.87B; Losses Continue Despite Increased R&D Investment